SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-14-088437
Filing Date
2014-03-07
Accepted
2014-03-07 12:22:59
Documents
2
Group Members
JON M. PLEXICOSTONEPINE CAPITAL MANAGEMENT, LLCTIMOTHY P. LYNCH

Document Format Files

Seq Description Document Type Size
1 SC 13D d688390dsc13d.htm SC 13D 86154
2 EX-1 d688390dex991.htm EX-99.1 4875
  Complete submission text file 0001193125-14-088437.txt   92576
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Subject) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-79091 | Film No.: 14676066
SIC: 2834 Pharmaceutical Preparations

Mailing Address 475 GATE FIVE RD., SUITE 320 SAUSALITO CA 94965
Business Address 475 GATE FIVE RD., SUITE 320 SAUSALITO CA 94965 415.331.7100
STONEPINE CAPITAL L P (Filed by) CIK: 0001370042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D